Phase 1b/2 Clinical Trial of Neoadjuvant Pembrolizumab Plus Concurrent Chemoradiotherapy With Weekly Carboplatin and Paclitaxel in Adult Patients With Resectable, Locally Advanced Adenocarcinoma of the Gastroesophageal Junction or Gastric Cardia
Phase of Trial: Phase I/II
Latest Information Update: 07 Sep 2017
At a glance
- Drugs Pembrolizumab (Primary) ; Carboplatin; Fluorouracil; Folinic acid; Oxaliplatin; Paclitaxel
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 01 Sep 2017 Status changed from recruiting to suspended.
- 30 Jun 2017 Planned End Date changed from 1 Apr 2018 to 15 Apr 2018.
- 30 Jun 2017 Planned primary completion date changed from 1 Apr 2018 to 15 Apr 2018.